Atlas Trials

Camurus AB

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Camurus AB

RecordFirmDate
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly (NCT07583563)Camurus AB2026-06-05
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD (NCT05281328)Camurus AB2022-06-28
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET (NCT05050942)Camurus AB2021-10-22
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly (NCT04125836)Camurus AB2019-10-10
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly (NCT04076462)Camurus AB2019-08-19
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) (NCT02299089)Camurus AB2015-01-01
Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer (NCT02212197)Camurus AB2014-09-01
A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis (NCT01684566)Camurus AB2013-02-01
Effects of Mucoprotective Product on Xerostomia (NCT01316393)Camurus AB2011-02-01

Track Camurus AB automatically

Every clearance here is in the API, with alerts when new ones post.